Laboratory test results

Notify the primary health care provider of all changes in the patient s general condition, the appearance of adverse reactions, and changes in laboratory test results. 

MANAGING HONE MARROW SUPPRESSION. Bone marrow suppression is a potentially dangerous adverse reaction resulting in decreased production of blood cells. Bone marrow suppression is manifested by abnormal laboratory test results and clinical evidence of leukopenia, thrombocytopenia, or anemia For example, there is a decrease in the white blood cells or leukocytes (leukopenia), a decrease in the thrombocytes (thrombocytopenia), and a decrease in the red blood cells, resulting in anemia Fhtients with leukopenia have a decreased resistance to infection, and the nurse must monitor them closely for any signs of infection. 

Solutions used to manage body fluids are often administered IV. Before administering an IV solution, the nurse assesses the patient s general status, reviews recent laboratory test results (when appropriate), weighs the patient (when appropriate), and takes the vital signs. Blood pressure, pulse, and respiratory rate provide a baseline, which is especially important when the patient is receiving blood plasma, plasma expanders, or plasma protein fractions for shock or other serious disorders. 

LC is a 51 -year-old female with a history of CHD (stent placement in the left anterior descending coronary artery 3 years prior) and type 2 diabetes who is referred to you for follow-up of her cholesterol. She is taking simvastatin 20 mg once daily in the evening for her cholesterol, and metformin 2000 mg once daily in the evening and piogliti-zone 15 mg once daily for diabetes. Her diabetes is well controlled. Her laboratory test results are within normal limits, except for her fasting lipid profile total cholesterol 215 mg/dL (5.57 mmol/L), triglycerides 135 mg/dL (1.53 mmol/L), HDL cholesterol 51 mg/dL (1.32 mmol/L), and LDL cholesterol 137 mg/dL (3.55 mmol/L). 

In the emergency department, a chest x-ray was normal. The following laboratory test results were obtained ... 

Type Laboratory Test Result Interpretation of Panel... 

Assess kidney function by evaluating a patient s signs and symptoms, laboratory test results, and urinary indices. Calculate a patient s creatinine clearance to evaluate the severity of kidney disease. 

Assess the patient s symptoms and laboratory test results to determine if patient-directed... 

Laboratory Test Results - Swelling Clay Stabilizers... 

FDA device regulation is focused on the device and the device manufacturer. CLIA, on the other hand, focuses on laboratory quality, including the quality of the laboratory test results provided by the devices used, whether developed in-house or as a test kit in commercial distribution to multiple laboratories. The programs differ substantially in approaches and in data requirements. FDA requires unique submissions for each test under its purview, evaluates both performance and labeling, and requires demonstration of analytical validity and clinical validity as appropriate. CLIA inspects laboratories using a system approach based on key probes of the operating system. CLIA requires a demonstration of analytical performance and quality control but does not require a showing of either clinical validity or clinical utility. 

The number of positively charged ions (cations) in the body must always be equal to the number of those negatively charged (anions). However, some negatively charged substances are not measured by the clinical laboratory tests, resulting in a net deficiency of anions between 8 to 16 milliequivalents/ liter. This value is commonly referred to as the anion gap, and it may be estimated as follows ... 

Which of the following sets of laboratory test results would most likely have been obtained for this patient ... 

Monitoring Monitor renal function frequently during amphotericin B therapy. It is also advisable to monitor liver function, serum electrolytes (particularly magnesium and potassium), blood counts, and hemoglobin concentrations on a regular basis. Use laboratory test results as a guide to subsequent dose adjustments. Monitor complete blood count and prothrombin time as medically indicated. 

Andco Environmental Processes, Inc., "Laboratory Test Results on Electrochemical Metal Removal."... 

In addition a wax deposition test was conducted 1n the field during the production test of well 31/2-14 in order to substantiate the laboratory test results. 

Laboratory test results are not helpful in predicting surface ignition results in engines, because it is difficult to devise a laboratory test procedure which will reproduce sufficiently well the condition to which fuel is exposed in an engine without having the laboratory test device approach the mechanical complexity of the engine. 

Co-administration of ezetimibe and fenofibrate in 32 healthy subjects with hypercholesterolemia (6) resulted in no significant changes in laboratory test results, including enzymes indicative of muscle or liver injury. 

Naturally, while awaiting additional investigation or laboratory test results, it may be necessary for preliminary reports, status reports, and draft reports. However, the final incident investigation report must satisfy the requirements of the OSHA Process Safety Management standard. An OSHA PSM report shall, at a minimum, include ... 

What blood tests would she have for this condition What should the normal range be for the laboratory test results and what levels would you expect Mrs Smith to have before treatment ... 

The investigator must sign and date the final end-of-study (termination) page of the CRF verifying that the data entered are accurate and complete. This page is completed after the study procedures and visits per protocol requirements have been completed all applicable laboratory test results have been re-... 

Type I Hazardous properties - Epidemiological evidence indicates inherent hazardous properties for a substance but existing laboratory test results lead to the conclusion that the substance is non-dangerous . - Evidence indicates endocrine disruption but Member States do not agree on the reliability of the findings. - Evidence indicates that metabolites or biodegradation products possess similar hazardous properties as the parent compound. 

---